Antibody Therapeutics for Life

Notices


No Title Written by Written date Inquire
53   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to attend to JP Morgan's Korea Conference 2019 (February 21-22).   관리자   2019-02-07   531  
52   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine was invited to attend as MAB working group expert for EDQM MAB Experts meeting   관리자   2019-02-07   339  
51   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine, Dr. Weon Sup Lee, Head of R&D Center, Dr. Sung Woo Kim, Head of BD were invited by JP Morgan Healthcare Confe   관리자   2019-02-07   2,422  
50   Quarterly Magazine KoNECT 14호(2018.12)_Interview of Dr. Jin-San Yoo   관리자   2019-01-14   370  
49   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Weon Sup Lee, Head of R&D center and PharmAbcine R&D staffs have attended and presented their R&D progress of both TTAC-0001 (Tanibirumab) and PMC-309 projects funded by KDDF   관리자   2019-01-14   390  
48   Interview of Dr. Jin-San Yoo, CEO of PharmAbcine with informa   관리자   2019-01-14   359  
47   PharmAbcine, a clinical stage immuno-oncology company announced that PharmAbcine is so proud to be a sponsor of the 11th COGNO Annual Scientific Meeting,   관리자   2019-01-14   2,756  
46   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to present at the 73rd Annual Conference of KAOBS.   관리자   2019-01-14   354  
45   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine has presented as invited speaker at GBC 2018 on June 26-29, 2018   관리자   2019-01-14   330  
44   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited as a chairman of the session of the antibody therapeutics at BIOPLUS 2018 on September 6-9, 2018.   관리자   2019-01-14   336